A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementiaShifu Xiao, Raoli He, Shengdi Chen et al.|Alzheimer s Research & Therapy|2021Cited by 200
In a Rat Model of Acute Liver Failure, Icaritin Improved the Therapeutic Effect of Mesenchymal Stem Cells by Activation of the Hepatocyte Growth Factor/c-Met PathwayLu Wang, Weihong Kuang|Evidence-based Complementary and Alternative Medicine|2019Cited by 16